Our most widely read blogs from 2022
It’s been another momentous year for the global life sciences industry. Ever since the pandemic...
BioStrand Omics Analysis Blog:
Precision medicine
Notes from BioTechX 2022
I recently had the privilege of representing the BioStrand Team at BioTechX, Europe’s largest...
Why we love multi-omics analysis
The key challenge to understanding complex biological systems is that they cannot be simply decoded...
Key elements of successful AI-native drug discovery
The use of AI in drug discovery has been progressively expanding over the past decade. Over the...
What is a biomarker?
A biomarker, or biological marker, broadly refers to a range of objectively, accurately, and...
Precision drugs for the precision medicine era
Currently, chemotherapy, using cytotoxic small molecules to kill cancer cells, is the predominant...
What is precision medicine?
In 1999, an innovative collaboration between 10 of the world’s largest pharmaceutical companies,...
A brief retrospective on our second blogiversary
It’s been an eventful two years, to the month, since we launched our omics and analysis blog. Our...
Accelerate Biomarker Discovery with Artificial Intelligence
Biomarkers play a critical role in realizing the true potential of precision medicine. As accurate...
Top 4 challenges of equitable precision medicine
In our previous articles on precision medicine, we reviewed how advances in precision medicine...
AI-powered genomics to advance precision medicine
Sir William Osler, often called the father of modern medicine, was among the first to articulate a ...